|

SI-B001 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 2

Top Sponsors

  • Sichuan Baili Pharmaceutical Co., Ltd.3

Indications

  • Cancer3
  • Squamous Cell Carcinoma of Head and Neck1
  • Head and Neck Squamous Cell Carcinoma1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other3 trials

A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase 2
A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1/2
A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.